Saudi Arabia is rewriting the story of cancer care in the Middle East. Once dependent on conventional chemotherapy and late-stage interventions, the Kingdom is now investing heavily in precision oncology—treatments that match the unique molecular profile of each patient’s tumor. This transformation is driven by Vision 2030, expanding genomic testing capacity, new specialized cancer centers,